Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy (TQL)

Jens Borglum Neimann

Status: Withdrawn

Conditions: Cholecystitis; Pain

Treatments: Drug: Ropivacaine; Drug: saline

Study type: Interventional

Funder types: Other

Identifiers

NCT02225418

2013-001364-30 (EudraCT Number)

BBH-TQL-LC

Details and patient eligibility

About

The TQL block may prove a valuable method for treating postoperative pain following scopic removal of the gall bladder.

The trial will compare active TQL block versus placebo TQL block after said operation.

The hypothesis is that active TQL block significantly will reduce postoperative pain following scopic removal of the gall bladder compared with placebo TQL block.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• scheduled for elective laparoscopic cholecystectomy
• received oral and written information about the trial
• American Society of Anaethesiologists (ASA) classification 1-3
• NRS score > 3 upon arrival at the PACU area

Exclusion criteria

• Cannot cooperate
• Does not speak or understand Danish
• Allergy towards drugs used in the trial
• Large daily consumption of opioids
• Known alcohol og medicin abuse
• Difficult or impossible by ultrasound to visualise the intended nerve/tissue structures necessary to perform block
• Pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

0 participants in 2 patient groups

Placebo TQL block

Sham Comparator group

Description:

30 ml single shot TQL block with saline 0,9%

Treatment:

Drug: saline

Active TQL block

Active Comparator group

Description:

30 ml single shot TQL block with ropivacaine 0,75%

Treatment:

Drug: Ropivacaine